Evidence map›Paper›PMID 24268774›Full record

ArticleCell reports2013

Genome-wide mapping of transcriptional start sites defines an extensive leaderless transcriptome in Mycobacterium tuberculosis.

Teresa Cortes, Olga T Schubert, Graham Rose, Kristine B Arnvig, Iñaki Comas, Ruedi Aebersold, Douglas B Young

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 198 papers.

0numbers the graph read from it
0cells of the map it votes in
198citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

198 citing papers in PubMed, 330 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. ARNA (New York, N.Y.) · 2026
    Article
  9. Article
  10. Regulation of the Expression ofAntibiotics (Basel, Switzerland) · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Journal of bacteriology · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Widespread loss-of-function mutations implicating preexisting resistance to new or repurposed anti-tuberculosis drugs.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2024
    Article

138 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Teresa CortesDivision of Mycobacterial Research, MRC National Institute for Medical Research, Mill Hill, London NW7 1AA, UK. Electronic address: tcortes@nimr.mrc.ac.uk.
Olga T SchubertDepartment of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland; Systems Biology Graduate School, 8057 Zurich, Switzerland.
Graham RoseDivision of Mycobacterial Research, MRC National Institute for Medical Research, Mill Hill, London NW7 1AA, UK.
Kristine B ArnvigDivision of Mycobacterial Research, MRC National Institute for Medical Research, Mill Hill, London NW7 1AA, UK; Institute of Structural and Molecular Biology, University College London, London WC1E 6BT, UK.
Iñaki ComasGenomics and Health Unit, Centre for Public Health Research (FISABIO-CSISP), 46020 Valencia, Spain; CIBER in Epidemiology and Public Health, 28029 Madrid, Spain.
Ruedi AebersoldDepartment of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland; Faculty of Science, University of Zurich, 8057 Zurich, Switzerland.
Douglas B YoungDivision of Mycobacterial Research, MRC National Institute for Medical Research, Mill Hill, London NW7 1AA, UK; Centre for Molecular Bacteriology and Infection, Imperial College London, London SW7 2AZ, UK. Electronic address: dyoung@nimr.mrc.ac.uk.
ETH Zurich · CHFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESImperial College London · GBInstitute of Structural and Molecular Biology · GBLife Science Zurich · CH

Funding

Medical Research Council MC_U117581288Medical Research Council U117581288
6 · The paper itself

Abstract

Deciphering physiological changes that mediate transition of Mycobacterium tuberculosis between replicating and nonreplicating states is essential to understanding how the pathogen can persist in an individual host for decades. We have combined RNA sequencing (RNA-seq) of 5' triphosphate-enriched libraries with regular RNA-seq to characterize the architecture and expression of M. tuberculosis promoters. We identified over 4,000 transcriptional start sites (TSSs). Strikingly, for 26% of the genes with a primary TSS, the site of transcriptional initiation overlapped with the annotated start codon, generating leaderless transcripts lacking a 5' UTR and, hence, the Shine-Dalgarno sequence commonly used to initiate ribosomal engagement in eubacteria. Genes encoding proteins with active growth functions were markedly depleted from the leaderless transcriptome, and there was a significant increase in the overall representation of leaderless mRNAs in a starvation model of growth arrest. The high percentage of leaderless genes may have particular importance in the physiology of nonreplicating M. tuberculosis.

Indexed as

Transcription Initiation Site5' Untranslated RegionsChromosome MappingGene Expression ProfilingGene Expression Regulation, BacterialMycobacterium tuberculosisPromoter Regions, GeneticSequence Analysis, RNATranscription, GeneticTranscriptome5' Untranslated Regions

Identifiers

PMID24268774
PMCPMC3898074
OpenAlexW2155347381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.